Table 3.
Results of cerebrospinal fluid analysis
| Group 1 | Group 2 | p value | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Range | N | Mean | SD | Range | N | ||
| CSF findings | |||||||||
| CSF white cell count (leucocytes/µl) | 103.00 | 142.87 | 11–540 | 13 | 52.17 | 66.15 | 6–268 | 18 | 0.173 |
| CSF total protein (mg/l) | 1.219 | 967 | 470–3710 | 11 | 865.06 | 475.83 | 407–1931 | 16 | 0.199 |
| CSF lysozyme (ng/ml) | 4.25 | 0.35 | 3.9–4.6 | 2 | 3.07 | 1.80 | 1.5–6.9 | 7 | – |
| CSF neopterin (ng/ml) | 5.20 | 1.78 | 2.5–6.9 | 4 | 4.66 | 4.10 | 2.1–15 | 14 | – |
| CSF sIL-2R (U/ml) | nA | nA | nA | 0 | 135.43 | 35.69 | 129–182 | 3 | – |
| Laboratory findings | |||||||||
| Serum ACE (U/l) | 151.00 | 74.00 | 77–225 | 2 | 79.53 | 11.28 | 70.2–98.6 | 4 | – |
| Serum lysozyme (mg/l) | nA | nA | nA | 0 | 30.05 | 16.13 | 18.2–73.9 | 10 | – |
| Serum neopterin (ng/ml) | nA | nA | nA | 0 | 3.94 | 1.70 | 2.8–7.3 | 5 | – |
| Serum sIL-2R (U/ml) | 975.50 | 186.50 | 789–1162 | 2 | 1512.29 | 537.57 | 818–2433 | 7 | – |
| Serum calcium | nA | nA | nA | 0 | nA | nA | nA | 0 | – |
N = patients with elevation of the regarding parameter and exact value available; Upper limit of normal: CSF cell count 5/µl, CSF total protein > 400 mg/l, CSF lysozyme > 62 ng/ml, CSF neopterin > 1.5 ng/ml, CSF sIL-2R > 50 U/ml, serum ACE > 70 U/l, serum lysozyme > 17 mg/l, serum neopterin > 2,5 ng/ml, serum sIL-2R > 623 U/ml